The user is inquiring about patents related to microneedle technology for continuous monitoring of progesterone and estradiol.
What is microneedle technology for hormone monitoring?
Microneedle patches utilize tiny needles, typically less than 1 millimeter in length, to penetrate the outermost layer of the skin. These microneedles can be designed to extract interstitial fluid, which contains hormones like progesterone and estradiol, allowing for continuous or frequent monitoring without the need for blood draws [1]. This approach offers a less invasive method for tracking hormonal fluctuations, which can be particularly relevant for fertility tracking, hormone replacement therapy, and diagnosing endocrine disorders.
Are there patents for microneedle devices monitoring progesterone and estradiol?
Patents exist for microneedle devices and systems designed for the continuous monitoring of various analytes, including hormones like progesterone and estradiol. These patents often cover the microneedle array design, materials used, methods of analyte extraction and detection, and the integration of these components into wearable devices [1, 2].
How do these microneedle patents work?
Microneedle patents typically describe the physical structure of the microneedles, which can be solid, hollow, or coated with active substances. For continuous monitoring, microneedles may be integrated with sensors or reservoirs capable of collecting and analyzing interstitial fluid. The patents detail how these devices facilitate the transdermal delivery or extraction of substances and how this process enables real-time or near-real-time measurement of hormone levels [1, 3].
When do patents for microneedle hormone monitoring expire?
The expiration dates of patents for microneedle hormone monitoring technology vary depending on the specific patent, its filing date, and any extensions granted. Patents generally provide exclusivity for a set term, typically 20 years from the filing date, though this can be influenced by factors like patent term adjustments. Information on specific patent expiration dates can be found through patent databases and specialized services like DrugPatentWatch.com [4].
Who is developing microneedle technology for hormone monitoring?
Research and development in microneedle technology for hormone monitoring involves various entities, including academic institutions, biotechnology companies, and medical device manufacturers. Companies are exploring applications for fertility, women's health, and personalized medicine, aiming to provide more convenient and accurate ways to track hormonal changes.
What are the potential benefits of microneedle hormone monitoring?
The primary benefit of microneedle-based hormone monitoring is its minimally invasive nature compared to traditional blood sampling. This can lead to increased patient compliance, more frequent data collection, and the potential for earlier detection of hormonal imbalances. Continuous monitoring can provide a more comprehensive picture of hormone dynamics than intermittent blood tests [1].
What are the challenges and risks associated with microneedle technology?
Challenges for microneedle technology include ensuring consistent analyte extraction, accurate detection in interstitial fluid, and the long-term stability and biocompatibility of the device. Potential risks, though generally considered low, could include skin irritation, localized inflammation, or infection at the microneedle insertion site, depending on the design and usage. The regulatory pathway for such novel medical devices also presents a hurdle for widespread adoption [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://drugpatentwatch.com/
[3] https://drugpatentwatch.com/
[4] https://drugpatentwatch.com/